SHAREHOLDERS' DEFICIT

3 Months Ended

Sep. 30, 2023

Stockholders' Equity Note [Abstract]

SHAREHOLDERS' DEFICIT

SHAREHOLDERS' DEFICIT:

Stock-Based Employee Compensation:

During the three months ended September 30, 2023, the Company granted restricted stock units as follows:

	Three Months Ended September 30, 2023
Restricted stock units (RSUs)	259,403

The RSUs granted during the three months ended September 30, 2023, vest in equal amounts over a three-year period subsequent to the grant date.

Total compensation cost for stock-based payment arrangements totaling $0.6 and $0.5 million for the three months ended September 30, 2023 and 2022, respectively, was recorded within general and administrative on the unaudited Condensed Consolidated Statements of Operations.

Share Issuance Program:

In fiscal year 2021, the Company filed a $150.0 million shelf registration statement and $50.0 million prospectus supplement with the Securities and Exchange Commission (SEC) under which it may offer and sell, from time to time, up to $50.0 million worth of its Class A common stock in "at-the-market" offerings. During the three months ended September 30, 2023 and 2022, the Company did not issue any shares. As of September 30, 2023, $11.6 million remains under the prospectus supplement, which equates to 16.5 million shares based on the share price as of September 30, 2023.